Arecor Therapeutics Is A Biopharmaceutical Company Based In Littlechesterfordukfounded In 2007Originally A Contract Research Organizationit Transitioned To A Biotechnology Firm In 2015 Under Theleadership Of Ceo Sarah Howellarecor Went Public In June2021Successfully Raising A 20 Million Thecompany Specializes In Developing Innovativetherapeutics Using Its Proprietary Arestata C Platformwhich Improves Thestabilitydeliveryand Efficacy Of Existing Drugsarecor S Portfolio Includes Clinical Stageinsulin Candidates For Diabetes And Obesityas Well As Oral Peptidedelivery Technologythecompany Collaborates With Pharmaceutical And Medtech Partnersincluding Hikma Pharmaceuticals And Inhibrixto Enhancedrug Performancearecor Generates Revenuethrough Licensing Agreementswith Plans To Becomeself Funding By 2025
